According to the American Autoimmune Related Diseases Association (AARDA), autoimmune diseases affect around 50 million Americans. It is considered as one of the leading causes of mortality in young and middle-aged women in the United States. An autoimmune disease occurs when body’s own cells are identified as foreign element and immune system reacts against to its “self” cell. Antibody testing is used to evaluate this disorder that affect tissues and organs throughout systemic body. The global anti-nuclear antibody (ANA) testing market exhibits rapid growth due to rising prevalence of autoimmune disorder and demand for advanced test kits. Availability of novel biomarkers and high adoption rate of multiplex assay kits further fuels the demand of global antinuclear antibody testing market.
The report titled “Antinuclear Antibody Tests Market - Growth, Future Prospects and Competitive Analysis, 2021-2029” offers strategic insights into the overall antinuclear antibody test market along with the market size and estimates for the duration 2019 to 2029. The said research study covers in-depth analysis of multiple market segments based on type of product, technique, disease and different geographies. The product types studied for analyzing the overall global antinuclear antibody test market are majorly segmented into reagent & assay kits, software & services and systems. The global antinuclear antibody tests market is segmented by technique type into ELISA, immunofluorescence assay and multiplex assay. By disease, global antinuclear antibody tests market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, scleroderma and other diseases.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global antinuclear antibody tests market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global antinuclear antibody tests market. This report concludes with company profiles section that highlights major information about the key players engaged in global antinuclear antibody tests market. In-depth competitive environment analysis and historical (2019) market size data are also provided in the report.
Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the vascular grafts market. The key players profiled in this report are Alere Inc., EUROIMMUN AG, ERBA Diagnostics, Inc., Trinity Biotech plc, Bio-Rad Laboratories, Inc., Immuno Concepts, Thermo Fisher Scientific,Inc., Antibodies,Inc., Inova Diagnostics, Zeus Scientific, Inc. and others.
This product will be delivered within 2 business days.
The report titled “Antinuclear Antibody Tests Market - Growth, Future Prospects and Competitive Analysis, 2021-2029” offers strategic insights into the overall antinuclear antibody test market along with the market size and estimates for the duration 2019 to 2029. The said research study covers in-depth analysis of multiple market segments based on type of product, technique, disease and different geographies. The product types studied for analyzing the overall global antinuclear antibody test market are majorly segmented into reagent & assay kits, software & services and systems. The global antinuclear antibody tests market is segmented by technique type into ELISA, immunofluorescence assay and multiplex assay. By disease, global antinuclear antibody tests market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, scleroderma and other diseases.
Geographically, the global antinuclear antibody tests market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global antinuclear antibody tests market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global antinuclear antibody tests market. This report concludes with company profiles section that highlights major information about the key players engaged in global antinuclear antibody tests market. In-depth competitive environment analysis and historical (2019) market size data are also provided in the report.
Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the vascular grafts market. The key players profiled in this report are Alere Inc., EUROIMMUN AG, ERBA Diagnostics, Inc., Trinity Biotech plc, Bio-Rad Laboratories, Inc., Immuno Concepts, Thermo Fisher Scientific,Inc., Antibodies,Inc., Inova Diagnostics, Zeus Scientific, Inc. and others.
Based on the type of products, the global antinuclear antibody tests market is segmented as follows:
- Reagents & Assay Kits
- Software & Services
- Systems
Based on the type of techniques, the global antinuclear antibody tests market is segmented as follows:
- Elisa
- Immunofluorescence Assay
- Multiplex Assay
Based on the type of diseases, the global antinuclear antibody tests market is segmented as follows:
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjögren’s Syndrome
- Scleroderma
- Other Diseases
For the purpose of this study, the global antinuclear antibody tests market is geographically categorized into:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Antinuclear Antibody Tests: Market Dynamics and Future Outlook
Chapter 4. Global Antinuclear Antibody Tests Market, by Product Type, 2019 - 2029 (US$ Mn)
Chapter 5. Global Antinuclear Antibody Tests Market, by Technique Type, 2019 - 2029 (US$ Mn)
Chapter 6. Global Antinuclear Antibody Tests Market, by Disease Type, 2019 - 2029 (US$ Mn)
Chapter 7. Global Antinuclear Antibody Tests Market, by Geography, 2019 - 2029 (US$ Mn)
Chapter 8. Company Profiles
Companies Mentioned
- Alere Inc.
- EUROIMMUN AG
- ERBA Diagnostics Inc.
- Trinity Biotech plc
- Bio-Rad Laboratories Inc.
- Immuno Concepts
- Thermo Fisher Scientific,Inc.
- Antibodies,Inc.
- Inova Diagnostics
- Zeus Scientific Inc